Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification

<div>Enrichment analysis of GDFMD in the treatment of WD liver damage. Top six BP, CC, and MF items extracted from GO enrichment analysis (a). Top 30 pathways extracted from KEGG enrichment analysis (b). Representative enriched KEGG pathway with key targets labeled red (c).</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification 

Figure 2 | Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification 